Cryptohud reviewed Octa Market FX against the patterns we see most often in investment-fraud cases. The picture that emerged is one of elevated risk: Octa Market FX has drawn cautions from regulators who have flagged…
Cryptohud reviewed Fiscal Markets against the patterns we see most often in investment-fraud cases. The picture that emerged is one of elevated risk: Fiscal Markets leans on a registration that does not amount to genuine…
Cryptohud reviewed Perfectforextrading against the patterns we see most often in investment-fraud cases. The picture that emerged is one of elevated risk: Perfectforextrading has drawn cautions from regulators who have flagged operations associated with it.…
When SpotpayFX crossed our desk, we ran it through the same heads-up assessment we apply to every platform. The picture that emerged is one of elevated risk: SpotpayFX leans on a registration that does not…
We brought SwissTrade.pro onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: SwissTrade.pro has drawn cautions from…
Our analysts put Space World Capital on the Cryptohud control room and worked the signals in order. The picture that emerged is one of elevated risk: Space World Capital is structured through an offshore jurisdiction…
We brought Goldhunter Academy onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Goldhunter Academy has drawn…
We brought Exventor.net onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Exventor.net has drawn cautions from…
Cryptohud reviewed Gate Invest Markets against the patterns we see most often in investment-fraud cases. The picture that emerged is one of elevated risk: Gate Invest Markets operates without verifiable authorisation from any recognised financial…
We brought Pexotera onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Pexotera has drawn cautions from…